חומר אמבוליזציה DuoTEN לטיפול בטחורים

חומר אמבוליזציה ייעודי שנוסח כדי למקד ו להפחית את זרימת הדם אֶל כלי דם טחוריים, מקדמים הקלה יעילה בתסמינים וריפוי ב באופן זעיר פולשני.

DuoTEN הוא חדשני ו אָמִין embolization agent formulated to treat a wide range of עוֹרְקִי ו venous hemorrhoids, including pelvic, vulvar, gastrointestinal, colon, ו anal lesions. By combining DuoTEN עִם dextrose in a 1:1 or 1:2 ratio (depending on procedural preference), clinicians achieve מְדוּיָק, minimally invasive occlusion of hemorrhoidal vessels—leading to rapid symptom relief and מְשׁוּפָּר patient outcomes. Its easy-to-use design, cost effectiveness, ו comfortable application make DuoTEN a trusted choice for healthcare professionals working in various endovascular or proctological settings.

Key Features and Technology

DuoTEN + Dextrose (1:1 or 1:2 Mix)
  • Safe Embolization: The mixture establishes a אָמִין occlusive effect on hemorrhoidal vasculature while maintaining control over flow rate.
  • Adjustable Consistency: Depending on the proportion used, physicians can modulate viscosity for better vessel targeting or extended dwell time.
  • Wide Applicability: Addresses an array of hemorrhoid etiologies—pelvic, vulvar, gastrointestinal, colon, ו anal manifestations.
  • Targeted Vascular Shutdown: Localized embolization reduces abnormal blood flow and alleviates patient discomfort quickly.
  • Straightforward Mixing: Simple ratio-based combination with dextrose ensures minimal preparation time and consistent results.
  • Minimal Instrumentation: Employs standard endovascular or proctological delivery systems, streamlining procedure steps and lowering resource overhead.
  • Safe Embolization: The mixture establishes a אָמִין occlusive effect on hemorrhoidal vasculature while maintaining control over flow rate.
  • Adjustable Consistency: Depending on the proportion used, physicians can modulate viscosity for better vessel targeting or extended dwell time.
  • Wide Applicability: Addresses an array of hemorrhoid etiologies—pelvic, vulvar, gastrointestinal, colon, ו anal manifestations.
  • Targeted Vascular Shutdown: Localized embolization reduces abnormal blood flow and alleviates patient discomfort quickly.
  • Straightforward Mixing: Simple ratio-based combination with dextrose ensures minimal preparation time and consistent results.
  • Minimal Instrumentation: Employs standard endovascular or proctological delivery systems, streamlining procedure steps and lowering resource overhead.

יתרונות קליניים ואינדיקציות

Minimally Invasive Hemorrhoid Management
  • Decreased Surgical Burden: May reduce or avoid the need for more extensive surgical procedures, such as hemorrhoidectomy.
  • Rapid Symptom Relief: Embolization curtails bleeding and discomfort, enabling a quick return to normal activities.
  • Localized Occlusion: Embolization is restricted to the target vessels, minimizing systemic impact or risk of collateral damage.
  • Gentle Tissue Interaction: Formulation with dextrose fosters a biologically compatible environment, translating to less postoperative discomfort.
  • Fewer Resources: By offering a straightforward mixing protocol and single injection, clinicians reduce procedure time and consumables.
  • Lower Recurrence: Effective occlusion and reduced complication rates can drive down long-term management costs.
  • Multiple Hemorrhoid Types: Employed for varied hemorrhoidal anatomies (internal, external, vulvar, etc.), ensuring broad clinical utility.
  • Adapted to Routine Practice: Integrates seamlessly with existing endovascular or proctology-based delivery equipment.
  • Decreased Surgical Burden: May reduce or avoid the need for more extensive surgical procedures, such as hemorrhoidectomy.
  • Rapid Symptom Relief: Embolization curtails bleeding and discomfort, enabling a quick return to normal activities.
  • Localized Occlusion: Embolization is restricted to the target vessels, minimizing systemic impact or risk of collateral damage.
  • Gentle Tissue Interaction: Formulation with dextrose fosters a biologically compatible environment, translating to less postoperative discomfort.
  • Fewer Resources: By offering a straightforward mixing protocol and single injection, clinicians reduce procedure time and consumables.
  • Lower Recurrence: Effective occlusion and reduced complication rates can drive down long-term management costs.
  • Multiple Hemorrhoid Types: Employed for varied hemorrhoidal anatomies (internal, external, vulvar, etc.), ensuring broad clinical utility.
  • Adapted to Routine Practice: Integrates seamlessly with existing endovascular or proctology-based delivery equipment.